6:07 PM
 | 
Feb 28, 2012
 |  BC Extra  |  Company News

FDA updates statin labels

FDA approved several label changes for the statin class of cholesterol drugs, including eliminating the need for routine periodic monitoring of liver enzymes. The labels now recommend that liver enzyme tests should be performed before starting statin therapy and as clinically indicated thereafter. The agency...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >